Browsing Tag

Randomization

POINT Biopharma Completes Randomization in PNT2002’s Phase 3 SPLASH Trial

Eli Pacheco Jan 13, 2023 0

INDIANAPOLIS, Jan. 12, 2023 (GLOBE NEWSWIRE) -- POINT Biopharma Global Inc. (NASDAQ: PNT) (the “Company” or “POINT”), a company accelerating the discovery, development, and global access…

Health

Lumos Pharma Reaches 50% Randomization Milestone in Phase 2 OraGrowtH210 Trial…

Eli Pacheco Apr 11, 2022 0

- Interim Data Anticipated by End of 2022 - - Interim Data from PK/PD OraGrowtH212 Trial also Anticipated by End of 2022 - AUSTIN, Texas, April 11, 2022 (GLOBE NEWSWIRE) -- Lumos…